Search

The article focuses on the readership success of the journal "Haemophilia." The impact factor of the journal in 2006 is 3.073, a reflection on the quality of its articles. The 2006 articles of the journal were downloaded 115,564 times in the Blackwell's Synergy and other online hosts. The circulation of the journal continues to grow worldwide as indicated on its 5556 institutional subscriptions, 2761 consortia libraries with paid access and 2684 institutions in the developing countries.

Focuses on the research on molecules and viral diseases in the U.S. Activities of protein C in diseases; Dynamics of hemostatis; Role of tissue factor as a therapeutic agent; Consideration on the development of inhibitors as a major complication of hemophilic treatment.

Interviews Rosemary Biggs, an expert on hemophilia and founder of the Hemophilia Centers. Development of a method to measure factor VIII, the factor lacking in hemophilia; Center's members; Difference between Christmas disease and hemophilia.

The author comments on the growth of the journal "Haemophilia." It is reported that, in the year 2008, articles of the journal were downloaded 139,693 times from its web site. It is stated that, the journal wants to embrace the general trend of online only publication as well as, providing its authors with more timely publication. It is stated that, from January 2010, the journal's authors will be able to choose to have articles published in an online-only issue.

The author reflects on the creation of the periodical on haemophilia. The author mentions that the firsth North American editor of the journal was New England Hemophilia Centre's director Doreen Brettler who help to formulate and develop ideas. The author states that in October 1994, the first publication of "Haemophilia" was launched with a mission statement dedicated to the information exchange on the comprehensive care of haemophilia.

The article offers brief information on the journal and its editorial policies.

The article presents the authors' comments on plagiarism with specific reference to the journal "Haemophilia." It is stated that plagiarism can be subdivided into two main types, data and text plagiarism. According to the authors, data plagiarism is more serious as it may be possible that an author presenting data is being copied from another publication without attribution.

The author contemplates on the developments of the journal "Haemophilia." He states that while the journal has matured and improved, it has not changed its commitment to exchange information focusing on the comprehensive care of hemophilia. The author emphasizes optimism on the future of the journal in the year 2011, and expresses his excitement of its further growth as it celebrates its 18th year of publication. He also comments on the environmentalism of the journal.

The article mentions that the article "Mosaicism and Haemophilia," by C. K. Kasper and C. H. Buzin, from this periodical "Haemophilia" that was published online on October 30, 2009 in the Wiley Online Library has been retracted.

The article introduces the special issue of the journal "Haemophilia," which is dedicated to the lifetime achievements of Hans Brackmann.

The article presents the best practice guideline on publication ethics to protect research subjects, patients and experimental animals. The author stated that manuscripts must be accompanied by a statement that the experiments were undertaken with the understanding and appropriate informed consent of the human participants. The author said that the Materials and method section should clearly indicate the proper measures that were taken to minimize the pain or discomfort of experimental animals.

The editor welcomes the new members to editorial board of the journal and also outlines the policy discussions by the board.

The article reports that the journal "Haemophilia" has completed 10 years of publication and appropriately there is a newly designed cover to take us into the next decade. The launch issue was produced in October 1994 and represented a challenge taken up by Blackwell Science Ltd. and supported by haemophilia treaters particularly Pier Mannucci, Peter Jones and Shelby Dietrich. The field of haemophilia has always been one that changes rapidly. It provides one of the best examples in medicine of how advances in basic science and clinical research can, in a very short time, lead to advances in clinical practice.

Focuses on the unpredictable costs of the expenditure on hemophilia treatment within the block contracts in Great Britain. Improvement of quality factors and methods of administration; Introduction of recombinant factor VIII for hemophilia; Risk of CJD transmission through blood products.